Rank 81 • Biotech & Discovery
Inceptive
Develops generative AI models to design novel, highly targeted RNA therapeutics and optimize biological medicine production.
Visit website- Signal Score
- 82.6
- Total raised
- $120M
- Stage
- Series A
- Founded
- 2021
- Headquarters
- Palo Alto, USA
- Region
- North America
Their signal
Led by a co-author of the seminal Transformer paper, Inceptive pioneered biological software to license fully designed mRNA molecules, targeting complex diseases with unprecedented structural control.
Signal Score 82.6editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.